Takeda Simplifies Portfolio and Accelerates Deleveraging Through Two Divestitures
OSAKA, Japan--(BUSINESS WIRE)--May 8, 2019--Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) ("Takeda") today announced that it has entered into agreements to divest its X…
